Showing 3311-3320 of 4063 results for "".
- International Ophthalmology Panel Calls for Recognizing and Treating Childhood Myopia as a Diseasehttps://modernod.com/news/international-ophthalmology-panel-calls-for-recognizing-and-treating-childhood-myopia-as-a-disease/2481607/Responding to one of the greatest eye health issues in a generation, nine internationally recognized pediatric ophthalmologists have come together to call for greater recognition of childhood myopia as a disease and earlier treatment of children. Their perspectives are now available as a white pa
- Eyenovia Receives FDA Approval of Mydcombi, the First Ophthalmic Spray for Mydriasishttps://modernod.com/news/eyenovia-receives-fda-approval-of-mydcombi-the-first-ophthalmic-spray-for-mydriasis/2481603/Eyenovia announced that the FDA has approved Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short term pupil dilation is desired. This represents the first approved fixed dose combinatio
- Cassini Launches Cassini Connect Digital Cataract Surgery Suitehttps://modernod.com/news/cassini-launches-cassini-connect-digital-cataract-surgery-suite/2481601/Cassini announced the launch of the Cassini Connect, a digital cataract surgery suite compatible with most leading microscope brands, at the 2023 ASCRS meeting. Cassini Connect offers an integrated cataract surgery workflow and data solution, from pre-op
- Atia Vision Announces Presentation of First-In-Human Results with OmniVu IOL System at ASCRShttps://modernod.com/news/atia-vision-announces-presentation-of-first-in-human-results-with-their-novel-intraocular-lens-at-ascrs/2481598/Atia Vision announced the first clinical data on the patented OmniVu IOL System will be presented at the 2023 Annual Meeting of the American Society of Cataract Refractive Surgery (ASCRS) in San Diego, California. First-in-human findings will be shared by&n
- Harrow Launches FDA-Approved Iheezo at ASCRShttps://modernod.com/news/harrow-to-launch-fda-approved-iheezo-at-the-2023-ascrs/2481596/Harrow announced the launch of FDA-approved Ihezzo at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting being held May 5‑8, 2023, in San Diego, California. The Harrow commercial team will be available to discuss Iheezo and the entire Harrow
- Johnson & Johnson Vision to Present and Support 43 Company-Sponsored and Investigator-Led Studies at ASCRShttps://modernod.com/news/johnson-johnson-vision-to-present-and-support-43-company-sponsored-and-investigator-led-studies-at-ascrs/2481593/Johnson & Johnson Vision will present and support 43 company-sponsored and investigator-led studies evaluating innovation, outcomes and satisfaction rates across its surgical portfolio at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego, May 5-8
- Zeiss to Present New Surgical Workflow Innovations at ASCRShttps://modernod.com/news/zeiss-to-present-new-surgical-workflow-innovations-at-ascrs/2481589/Zeiss will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Surgery (ASCRS) annual conference from May 6-8, 2023, in San Diego. These products as part of the Zeiss Medical Ecosystem help enhance ophthalmic care within the cataract and corneal refr
- Johnson & Johnson Vision Receives FDA Clearance for its Elita Femtosecond Laserhttps://modernod.com/news/johnson-johnson-vision-receives-fda-clearance-for-its-elita-femtosecond-laser/2481573/Johnson & Johnson Vision announced that it has received FDA 510(k) clearance for the Elita Femtosecond Laser for the creation of LASIK flaps. Elita will be unveiled at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in San Diego, May 5-8
- EssilorLuxottica Unveils 4-Year Clinical Trial Results of its Essilor Stellest Lens athttps://modernod.com/news/essilorluxottica-unveils-4-year-clinical-trial-results-of-its-essilor-stellest-lens-at-arvo-at/2481572/EssilorLuxottica presented the 4-year clinical trial results of its Essilor Stellest lens for myopia control at the 2023 ARVO annual meeting in New Orleans. The findings show that Essilor Stellest lenses continue to exhibit strong efficacy in slowing myopia progression and axial ey
- Medical Consulting Group and Corcoran Consulting Group Announce Mergerhttps://modernod.com/news/medical-consulting-group-and-corcoran-consulting-group-announce-merger/2481571/Medical Consulting Group (MCG), a provider of consulting services to ophthalmic practices and companies, and Corcoran Consulting Group (CCG), a company specializing in billing, coding, and reimbursement issues for ophthalmology and optometry practices, today announced a definitive merger agreemen